| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.50M | 38.82M | 32.39M | 28.01M | 26.57M | 27.34M |
| Gross Profit | 30.53M | 31.56M | 28.91M | 25.15M | 21.88M | 22.86M |
| EBITDA | 8.26M | 9.50M | 7.55M | 5.89M | 5.22M | 6.55M |
| Net Income | 3.71M | 1.32M | 3.33M | 2.65M | 2.40M | 2.73M |
Balance Sheet | ||||||
| Total Assets | 57.32M | 59.99M | 51.81M | 45.98M | 41.59M | 39.22M |
| Cash, Cash Equivalents and Short-Term Investments | 12.23M | 16.29M | 13.97M | 10.90M | 12.14M | 10.05M |
| Total Debt | 1.36M | 1.20M | 1.46M | 1.46M | 1.68M | 2.04M |
| Total Liabilities | 25.63M | 28.36M | 21.64M | 18.62M | 15.75M | 15.38M |
| Stockholders Equity | 31.70M | 31.64M | 30.17M | 27.36M | 25.84M | 23.85M |
Cash Flow | ||||||
| Free Cash Flow | 5.91M | 12.07M | 5.65M | 5.76M | 3.74M | 4.69M |
| Operating Cash Flow | 9.24M | 12.15M | 8.96M | 5.89M | 5.53M | 6.70M |
| Investing Cash Flow | -8.02M | -8.93M | -4.25M | -5.81M | -1.74M | -1.95M |
| Financing Cash Flow | -1.34M | -1.37M | -1.34M | -1.61M | -1.15M | -5.33M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £109.80M | 79.03 | 4.16% | 0.79% | 19.82% | -60.20% | |
68 Neutral | £213.25M | 37.63 | 5.22% | 0.80% | 19.00% | -53.85% | |
68 Neutral | £155.40M | -33.80 | -2.11% | ― | 31.86% | -115.22% | |
65 Neutral | £327.56M | 41.80 | 7.57% | 1.04% | 2.55% | 16.38% | |
64 Neutral | £106.59M | 6,693.30 | 1.51% | 0.80% | 4.66% | 88.89% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |